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Small  IgM  ÷,  IgD  ÷  B  cells  can  switch  to  the  production  of other  classes  (and 
subclasses)  of immunoglobulin  (Ig)  (1-4).  This  switch  can  be  induced  by  either 
antigenic (5, 6) or mitogenic stimulation (7). The nature of the antigen (8), the site of 
antigen injection (9), and the nature of the T  cell response (8,  10-13)  can determine 
the  class  of Ig  produced  in  vivo.  In  particular,  the  switch  in  isotype synthesis  is 
relatively T  cell dependent (8,  10,  11). Furthermore, T  cells can influence the subclass 
of IgG  secreted  by  B  cells  (12,  13).  However,  in  low  density  cell  cultures  in  the 
presence  of lipopolysaceharide  (LPS),  1  IgG  secretion  by  murine  B  cells  may  not 
require T  cells (5,  14-17). 
There  is mounting  evidence that  T  cell-derived factors can  profoundly influence 
the growth and maturation of lymphoid cells (18,  19). These factors can be obtained 
from T  cell hybridomas, lines, and clones. There are reports (20-25)  indicating that 
subsets of T  cells can  give isotype specific help,  i.e., can  enhance  the synthesis of a 
particular isotype. It was of interest, therefore, to determine whether T  cell lines and 
hybridomas produced factors that affected the isotype produced by B  cells. 
In the studies reported here we have used B cells stimulated by LPS to investigate 
the effect of several T  cell-derived supernatants  on  Ig isotype secretion. Our results 
suggest the existence of a  T  cell lymphokine(s) produced by a  T  cell hybridoma and 
two T  cell lines which can induce B  cell differentiation. In the presence of LPS, this 
B  cell differentiation factor(s)  (BCDF) 2 enhances IgG secretion by surface immuno- 
globulin (sIgG-) cells and, in particular, substantially increases the secretion of IgG1. 
* Supported by grants AI-12789 and AI-11851 from the National Institutes of Health. 
l Abbreviations used in this paper: AEF, allogeneic effect factor; BCDF, T cell-derived B cell differentiation 
factor; C', complement; CAS, supernatant from concanavalin A-activated spleen cells; Con A, concanavalin 
A; CSF, colony-stimulating factor; FACS, fluorescence-activated cell sorter; FCS, fetal calf serum; FITC, 
fluorescein isothiocyanate;  HCSF,  histamine  colony-stimulating  factor;  IL-1, IL-2, interleukin  1 and 2; 
LPS, lipopolysaccharide; MAF, macrophage-activation  factor; NRIg, normal rabbit Ig; PBS, phosphate° 
buffered saline; PFC,  plaque-forming  cell(s); RaS, rabbit anti-6 chain;  Ra#, rabbit anti-/~ chain;  Ray, 
rabbit anti-mouse y; RAMIg, rabbit anti-mouse Ig; RIA, radioimmunoassay; SDS-PAGE, sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis; sIg, surface immunoglobulin; TRF, T cell-replacing factor(s). 
We have previously reported  the induction  of polyclonal IgM secretion by supernatants  from T cell 
lines and hybridnmas  (26). Since these T cells also secrete TRF, we previously referred to this polyclonal 
activity as TRF. We have  recently shown that T  cell lines that do not  secrete conventional  TRF  a are 
capable of inducing polyclonal IgM secretion. Thus, we now refer to this activity as B cell differentiation 
factor for IgM (BCDF~). The relationship between BCDF~ and the BCDF defined in the present paper, 
which enhances polyclonal IgG secretion (BCDFv), is not clear. Therefore, in this report BCDF will be used 
to describe T cell-derived factors that can effect polyclonal Ig secretion of either isotype. 
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BCDF appears to be different from other known  lymphokines, such as interleukin  1 
(IL-1), interleukin  2  (IL-2), T  cell-replacing factor  (TRF),  some colony-stimulating 
factors  (CSF),  macrophage-activation  factors  (MAF),  and  immune  interferon 
(IFN-y). 
Materials  and  Methods 
Animals.  Female BALB/c mice (Cumberland Farms, Clinton, TN) were used at 8-16 wk of 
age. 
Deletion of T  Cells.  B  cells were prepared by treatment  of spleen cell suspensions with a 
monoclonal anti-Thy-1.2 (HO-13.4) and baby rabbit complement (C') (Pel-Freeze Biologicals, 
Rogers, AR). Alternatively, spleen cells were first treated with a combination of rat hybridoma 
antibodies against  Thy-l.2  (HO12.4),  LyT-1  (53.7.313),  and  LyT-2  (52.6.72),  followed by 
rabbit anti-mouse y chain and C', as described (26). These treatments abolished the proliferative 
response to eoncanavalin A  (Con A). 
Culture Conditions.  BALB/c B cells were cultured in flat-bottomed microtiter plates (Linbro 
Scientific Co.,  Hamden, CT)  at 0.5  ×  105-5  ×  105 cells/ml in RPMI  1640  with penicillin, 
streptomycin, and gentamycin (10 #g/ml), 50 #M 2-mercaptoethanol, and 10% fetal calf serum 
(FCS)  (Grand  Island  Biological  Co.,  Grand  Island,  NY).  Cultures  were  incubated  in  a 
humidified atmosphere of 83% N2,  10% CO2, 7% 02 at 37°C. 
Plaque-Forming Cell (PFC) Assay..  Enumeration of Ig-secreting cells was accomplished by the 
reverse plaque assay of Gronowicz et al. (27). The antiserum used for detecting IgM-seereting 
cells has been described (28). The anti-y serum was raised against free gamma chain (29) and 
did not develop plaques with IgM-secreting myelomas. 
Antibodies.  The preparation of affinity-purified  rabbit antibodies against mouse Ig (RAMIg), 
#  (Ra#), and y (Ray) heavy chains, and the hybridoma antibody, anti-~ (H10.4.22) has been 
described (30). The anti-y reacts with all four subclasses of IgG as determined by binding of the 
relevant myeloma proteins. Two monoelonal anti-Thy 1.2 antibodies were used (31); the mouse 
IgMx product of HO-13.4 hybridoma cells was obtained from the Cell Distribution Center of 
the Salk Institute (La Jolla, CA), and the rat IgG product of HO-12.4 hybridoma cells was 
obtained from Dr. Noel Warner (Becton, Dickinson & Co., Palo Alto, CA). The rat anti-Lyt-1 
and anti-Lyt-2 hybridomas (31)  were also obtained from the Cell Distribution Center of the 
Salk Institute. The purification of the monoelonal anti-Lyt-1 and anti-Lyt-2 antibodies has 
been described previously (26). Fluoreseein-isothiocyanate-conjugated  F(ab')2-rabbit  anti-mouse 
y (FITC-F(ab')2RAMy) has been described (32). 
Cell Sorting.  BALB/c splenocytes were stained with FITC-F(ab')2-Ray (67 #g/ml)  as de- 
scribed (32).  This reagent stains ~5%  of spleen cells. Stained cells were sorted sterilely on a 
FACS III (B-D FACS System, Becton, Dickinson & Co., Sunnyvale, CA). Scatter gates were set 
to exclude dead cells and erythrocytes. The brightest 15-20% cells were sorted from the negative 
population. After sorting, the cells were reanalyzed to determine the percentage of positive cells 
remaining in the negatively selected population. Typically <1% of the negatively sorted cells 
were positive. Sorted cells were pelleted and suspended in medium and treated with monoclonal 
anti-Thy-l.2 and C'. In some experiments, T  cells were killed before sorting; similar results 
were obtained with each of the two procedures. Sorted cells, along with stained unsorted cells 
or untreated cells, were then cultured as described above. 
T Cell Supernatants (Table I) 
HYnmDOMA FS7-6.18 CELLS (33).  These were obtained from  Dr.  P.  Marrack, and  were 
pulsed with Con A, and the supernatants prepared as previously described (26). 
T  CELL LINES PK 7.1.1a ANn PK 7.1.2.  Secondary ailoreactive AKR anti-C57BL/6  (B6) 
cells (104/ml) were subcultured weekly in the presence of irradiated (3,300  rad) B6 stimulator 
cells (106/ml) in medium supplemented with rat spleen Con A supernatant (CAS) as a source 
of IL-2 (34). These cells have been maintained in culture (75 cm  2 Falcon bottles, flat-bottomed, 
in 20-40 ml medium [Falcon Labwave, Oxnard, CA]) for >1 yr (34). Lymphokine release was 
induced after washing the cells in IL-2-free medium containing 2% FCS, pulsing them for 3 h 
with  10 #g/ml Con A, washing, and culturing for 24 h  in medium free of both IL-2 and Con 736  T  CELL-DERIVED B  CELL  DIFFERENTIATION FACTOR(S) 
TABLE  I 
Lymphokines Produced by T Cell Hybridomas and Long-Term Lines 
Lymphokine 
Cell desig-  CSF  Refer- 
nation  ence  IL-2  TRF  MAF  IFN-y  HCSF  BCDF 
GM  MEG  EO  E 
PK 7.1.1a  -  -  ND*  -  +  +  +  +  + 
PK 7.1.2  -  -  ND  -  +  +  +  +  + 
FS7-6.18  +  -  ND  ND  ND  ND  ND  ND  ND 
PC-AKR  -  -  +  +  +  +  -  -  - 
clone 29 
PC-AKR  -  -  +  +  ..... 
done 96 
B151KI2  -  +  ND  ND  ND  ND  ND  ND  ND 
C.C3.11.75  -  +  ND  ND  ND  ND  ND  ND  ND 
+  34 
+  34 
+  33 
-  34, 35 
34, 35 
36 
38, 39 
* Not determined. 
A. The supernatants  from these cells have been shown to lack IL-2 and TRF, but  to contain 
CSF and histamine-producing cell stimulating factor (HCSF)  (See Table I)  (34). 
Radioimmunoassay (RIA) for Secreted Ig.  Supernatants  from 6-d  cultures  of stimulated  cells 
were assayed  for the presence  of secreted  IgM and  IgG by a  solid phase  RIA as  previously 
described  (28).  Microtiter  plates  (Cooke  Engineering,  Alexandria,  VA)  were  coated  with 
affinity-purified  RAMIg  and  1%  FCS.  IgM  was  detected  with  [t2SI]Ra#  and  IgG  with 
[l~I]Ray. These reagents had negligible cross-reactivity (<1%) with inappropriate heavy chains 
or light chains. For quantitation, standard  curves using purified myeloma IgM (MOPC-104E) 
or mouse IgG were included in each assay. 
Radiolabeling ofLPS-treated B Cells.  B cells were cultured at 2 X  105/ml.in flat-bottomed 75- 
cm  2 flasks (Falcon Labware) with 20 #g/ml LPS (Salmonella typhosa, Difco Laboratories, Detroit, 
MI)  and  the appropriate  concentration of T  cell sup  ernatant.  After 6  d  cells were harvested 
and  washed  with  balanced  salt  solution.  0.3  x  107-1  X  107  cells  were  then  labeled  with 
[nH]leucine for 6  h  as previously described  (40).  Secreted material  was  dialyzed against  PBS 
before immunopreeipitation or column chromatography. 
Immunopredpitation and Sodium Dodecyl Sulfate-Polyac~ylamide Get  Electrophoresis (SDS-PAGE). 
Secreted material  (3H)  or samples from protein A-Sepharose columns (all or x2sI) were treated 
with saturating amounts of affinity-purified rabbit antibodies directed against mouse #, y chain 
or ovalbumin  (control).  Complexes were bound  to fixed S. aureus. The bacteria were washed 
with PBS, and the adherent  radioactive material was eluted by boiling in  1% SDS containing 
2-mercaptoethanol.  Samples of the eluate were electrophoresed on 7.5% SDS-PAGE. The areas 
under the #  and y chain peaks were then determined from the gel plots. 
Separation ~  IgG Subclasses by Protein A  Column Chromatography.  To identify subclasses of IgG 
secreted by [ H]leucine-labeled cells, a  modification of the method described by Ey et al.  (37) 
was used. Briefly, columns containing 2 ml of Sepharose-protein A  (1 mg protein A [Pharmacia 
Fine Chemicals,  Piseataway,  N J]  per ml Sepharose)  were washed  with 50 ml of PBS pH 8.0 
(1-2 ml) of [ H]leucine-labeled material, dialyzed into PBSs, were passed over  (PBSs). Aliquots  a 
the column, and the pH 8.0 fall through and wash were collected. The adherent  material was 
eluted stepwise with  10 ml PBS-pH 7.0,  0.1  M  Na citrate, pH 6.0 and Na citrate, pH 5.0. The 
fall through and the fractions eluting at each pH were dialyzed for  16 h  at 4°C against  PBS, 
pH 7.3 and the Ig immunoprecipitated from the dialyzed samples as described above. 
Separate experiments were performed to determine the elution profiles of each lgG subclass 
and  established  that  12sI-IgG1  (MOPC-21),  l~I-IgG2a  (RPC-5),  125I-IgG~b (MOPC-195),  and 
lZSI-IgG8 (J606)  eluted from the protein A  Sepharose column at pH 8.0 (yl), 6.0 (y2,),  and 5.0 
(yzu and yz), respectively. Moreover, it was found that the IgG eluted at pH 8.0 was not bound 
by S. aureus (at  pH  7.3), whereas the IgG eluted at pH 6.0 and  5.0 were bound.  This further 
confirmed  that  the  pH  8.0  eluate  contained  IgG1,  whereas  the  pH  6.0  and  pH  5.0  eluates ISAKSON,  PURLS,  VITETTA,  AND  KRAMMER  737 
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FIG.  1.  Effect of T  cell supernatants on IgG production by B cells. BALB/c B cells were cultured 
at  2  ×  105/ml  (4 ×  104/well)  for 6  d, then assayed for IgG-secreting cells by the reverse plaque 
assay. T  cell supernatants were used at the following concentration (vol/vol): FS7-6.18 supernatant 
25%; PK 7.1. la supernatant 2%; C.C3.11.75 supernatant 5%. 
contained IgG~, IgG2b, and IgG3,  respectively. Because IgG2b  and IgGa could not be separated 
by chromatography on protein A-Sepharose,  the pH 5.0 eluate will be referred to as IgG2b/ 
IgGa. In terms of the [3H]leucine-labeled Ig, 80-90% of [3H]leucine labeled IgM eluted at pH 
8.0, whereas the remainder eluted at pH 5-7. It is of interest  that the small amount of IgM 
eluting with IgG2b/IgG3 at pH 5.0 (~ 10%) bound to S. aureus, whereas that eluting with IgG1 
(pH &0) did not. 
Results 
Effect of Con A-Induced Supernatant from  FS7-6.18 and PK 7.1. la on Ig Production by B 
Cells.  We determined whether supernatant from the T  cell hybridoma FS7-6.18 and 
the  T  cell  lines  PK  7.1.1a  and  PK  7.1.2  could  enhance  the  LPS-induced  IgG 
production by splenic B cells in low density cultures. It was desirable to remove T 
cells  to  facilitate  interpretation  of the  results  because  some  supernatants  tested 
contained  lymphokines  that  could  activate  T  cells;  such  activated  T  cells  might 
influence the  B  cell response.  Therefore, T  cells were depleted by treatment  with 
either anti-Thy-l.2 plus C', or anti-Thy.l.2 plus anti-Lyt-1 and anti-Lyt-2 followed 
by rabbit  anti-  7  and C'. The results with both B  cell populations were similar.  As 
shown in Fig.  1, LPS induced IgG PFC in B cells cultured for 6 d. Supernatants from 
both  FS7-6.18  and  PK  7.1.1a  markedly enhanced  the  LPS-induced IgG response, 
whereas  neither  supernatant  appeared  to  elicit  a  significant  IgG  response  in  the 
absence of LPS (see below). Supernatants from line PK 7.1.2 had activity identical to 
that found in PK 7.1. la supernatant and have been used in similar experiments; for 
clarity, only results obtained with PK 7.1. la supernatants are presented. In contrast, 
supernatants  from C.C3.11.75  (38-39),  a  T  cell line,  and  B151K12  (36),  a  T  cell 
hybridoma (both of which produc~ TRF and induce B cells to secrete IgM) had no 
effect on IgG secretion (Fig. 1 and data not shown). This suggests that a conventionally 
defined  a TRF  is  not  responsible  for the  enhancement  of the  IgG  response  in  the 
presence of LPS. Supernatants from several other T  cell lines and clones tested in this 
system (see Table 1) were also found to be negative: BW5147 thymoma (one parent 
of FS7-6.18) , T33F6 hybridoma described by Pacifico and Capra (42), PC-AKR CL- 
96, which produces MAF and IFN-y (34,  35), and PC-AKR CL-29, which produces 
IFN-y, MAF, and several CSF (34). CAS uniformly suppressed the LPS-induced IgG 
PFC. Thus, IgG production was enhanced by supernatants from two T  cell lines and 
one T  cell hybridoma, and the activity of these supernatants  did not correlate with 
the presence of TRF, IL-2, MAF, GM-CSF, or Meg-CSF (see Table I). 
a TRF  is  used  here  to  denote  a  factor  that  can  replace  T  cells  in  the  in  vitro  response to  sheep 
erythrocytes, as defined by Schimpl and Wecker (47). 738  T  CELL-DERIVED  B  CELL  DIFFERENTIATION  FACTOR(S) 
Effect of Supernatant Concentration and Cell Density on IgG Secretion.  The relative potency 
of the two positive supernatants (FS7-6.18  and 7.1. la) was assessed (Fig. 2). The FS7- 
6.18 supernatant, at any concentration tested, only induced IgG PFC in the presence 
of LPS.  PFC  were  increased  approximately  fourfold  as compared  with  PFC  from 
cultures  treated  with  LPS  alone  (Fig.  2).  The  PK  7.1.1a  supernatant  was >10-fold 
more  potent  than  FS7-6.18  in  enhancing  an  LPS  response,  although  maximum 
responses obtained with each supernatant  were similar.  Although  FS7-6.18  did  not 
increase  the  LPS-induced  IgM  response  at  any  cell  density  tested  (Fig.  3),  IgG 
secretion was substantially enhanced at a cell number as low as 1 ×  105 cells/ml.  At 
cell densities below 105 cells/ml, an abrupt decline in the IgG response occurred. This 
may  reflect  a  requirement  for  accessory  cells  in  the  responder  cell  population. 
Analogous results were obtained with PK 7.1. la supernatant  (data not shown). The 
data in Fig. 3 reflect the total IgG secreted over the 6-d culture period determined in 
a  RIA;  similar results were obtained  in a  PFC  assay performed on day 6  of culture 
(data not shown). 
T Cell Supernatants Increase the Frequency of lgG-secreting  Cells.  One possible explana- 
tion for the enhanced IgG response induced by the T  cell supernatants would be that 
such supernatants simply  increased  the number of cells recovered at  the end of the 
culture  period.  This  was  an  important  consideration  because  the  FS7-6.18  often 
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Flo.  2.  Effect  of T  cell supernatant  concentration  on induction  of IgG secretion.  BALB/c  B  cells 
were cultured  at  2  x  105/ml  for  6  d  and assayed  for IgG secreting cells. Concentration  of T  cell 
supernatant  is  (vol/vol).  Data  for  the  PK  7.1.1a  and  FS7-6.18  supernatants  were  obtained  in 
separate experiments. 0, without  LPS; O, with LPS. 
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Fla.  3.  Effect  of cell  density  on  IgG  secretion.  BALB/c  B  cells  were  cultured  for  6  d  at  the 
indicated  initial  cell  densities.  Supernatants  were  assayed  for  IgM  and  IgG  by  solid  phase 
radioimmunoassay.  Concentration  of FS7-6.18  supernatant  was 25% (vol/vol). O, control; A, LPS; 
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enhanced the recovery of viable cells. Thus, the number of viable cells recovered after 
6  d  was  determined and used to calculate the PFC  frequency, i.e., number of IgG 
PFC per  1,000 recovered cells. As shown in Table II, both FS7-6.18 and PK 7.1.1a 
markedly increased the frequency of IgG secreting cells, and therefore both superna- 
tants appear to induce differentiation rather than simply increase recovery of viable 
cells. 
T  Cell Supernatants Induce IgG Secretion by IgG-  Cells.  The experiments presented 
above suggest that T  cell factor(s) from two sources can enhance the appearance of 
IgG-secreting cells. In order to determine whether these factors selectively induced 
differentiation of IgG-bearing cells or induced a  switch  in  IgG- cells, we removed 
IgG-bearing  cells  before  culture.  This  was  accomplished  using  the  fluorescence- 
activated cell sorter (FACS). Spleen cells were stained with fluoresceinated F(ab')a- 
rabbit anti-), then analyzed and sorted. This reagent typically stains 5% of BALB/c 
spleen cells. Gates were set such that the  15-20% most positively stained cells were 
excluded from the negatively selected population. Thus, even weakly positive cells 
were removed by this procedure. The positively selected cells were not cultured for 
technical reasons.  Negatively selected cells were then reanalyzed on the FACS and 
cultured in the usual manner; untreated cells and/or stained but unsorted cells were 
also cultured as controls. A typical experiment is shown in Fig. 4. It is apparent that 
the removal of IgG-positive cells has no effect on the IgG-response of the cells to LPS 
or LPS plus T  cell factors. Results similar to those shown in Fig. 4 were obtained in 
three other experiments. 
We also quantitated  the amount of radioactive IgG secreted by both sorted and 
unsorted  radiolabeled  cells.  Cells  were labeled  with  [aH]leucine,  and  the  secreted 
material was analyzed by immunoprecipitation with rabbit anti-), followed by SDS- 
PAGE. A typical gel profile is shown in Fig. 5. Similar cell numbers secreting identical 
acid-precipitable counts were used so that direct comparisons could be made.  It is 
obvious that  virtually identical amounts of IgG were secreted by both sorted and 
unsorted ceils.  In  addition,  the secreted material  from four cultures  (two separate 
experiments) was precipitated with RAMIg, and the quantity of secreted IgM and 
IgG was determined by calculating the areas under the H  chain peaks of the SDS 
gels.  Although some variability in  the total amount of IgG secreted was apparent, 
slgG- cells did not secrete substantially less IgG than uiasorted cells (4.4% decrease in 
IgG secretion by slgG- cells). 
TABLE II 
Effect of T Cell Supernatants on the Frequency of LPS-induced IgG-secreting 
Cells 
Experi-  Initial cell 
ment  density  None 
Addition to culture* 
FS7-6.18  PK 7.1.1a 
* See Legend to Fig. 1 for experimental details. 
:[: IgG PFC per 1,000 cells recovered. 
§ Not done. 
×  lOS/ml 
l  2  0.8:[:  7.8  ND§ 
2  2  0.3  19.2  ND 
3  1  2.0  9.0  24.0 740  T  CELL-DERIVED B  CELL DIFFERENTIATION FACTOR(S) 
No Addition 
PK 7.1.1o 
FS7-6.18 
1  2  3  4  5 
IgG PFC/Culture x 10  -3 
FIc.  4.  Induction of IgG secretion  in IgG- cells cultured with T cell supernatants in the presence 
of LPS. BALB/c B cells (prepared by treatment with anti-Thy-l.2 +  C') were stained with FITC- 
F(ab')2-Ra7 and positively staining cells were sorted away as described  in Materials and Methods. 
Three groups  of cells were then cultured in microtiter plates at 2 ×  10~/ml with 20 #g/ml LPS: D, 
untreated cells; ~, cells which were stained but not sorted;  and !  sorted (IgG-negative)  cells. After 
6 d cultures were assayed for IgG PFC. 
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Fro.  5.  Subclass  analysis  of the IgG secreted  by cultured B cells. IgG positive cells were sorted 
away as described in Materials and Methods and the legend to Fig. 4. Unsorted  (O) and sorted 
(C)), IgG negative cell populations were then cultured in 10-ml flasks at 2 ×  10S/ml for 6 d with LPS 
and FS7-6.18 supernatant  (20%). Equal numbers of cells (3 X  l0  n) were labeled with [SH]leucine 
and the secreted  material (which had equal amounts of TCA-precipitable counts)  was immunopre- 
cipitated with rabbit anti-y and S. aureus. After elution, samples were electrophoresed under reducing 
conditions on 7.5% SDS-polyacrylamide gels. The IgM 0~ chain) shown  in the gel was also bound 
by NRIg and S. aureus (not shown) and does not indicate the presence of anti-/× or anti-L antibodies 
in the anti-y serum. A portion of the IgG also bound directly to S. aureus (not shown) and reflects the 
presence of protein A-binding IgGs/IgGzw 
Furthermore,  as  shown  in Table  III,  a  comparison  of the  amount  of secreted  IgG 
and  IgM  showed  that:  (a)  cells treated  with  LPS  alone  secrete predominantly  IgM 
(average  of  96%),  and  (b)  addition  of either  FS7-6.18  or  PK  7.1.1a  supernatant 
resulted  in a  striking increase in IgG secretion  (average of 20 and  24% of the total Ig, 
respectively).  Taken  together,  these  results  suggest  that  the  T  cell  supernatants 
preferentially enhance  the LPS-induced  IgG secretion by slgG- ceils. 
Subclass Analysis  of the IgG Secreted  by  Cultured B  Cells.  Since T  ceils are  known  to 
influence  the subclass  as well as  the class  of IgG secreted  by  B  cells, we determined 
whether the T  cell supernatants  affected the subclass of IgG secreted by ceils cultured 
in the presence of LPS.  To quantitatively analyze the subclass of IgG secreted in the 
above experiments,  we labeled  equal  numbers  of LPS-treated  B  ceils  (+_  PK  7.1.1a 
supernatant)  with [3H]leucine on day 6 of culture; comparable amounts of [ZH]leucine ISAKSON, PURLS, VITETTA,  AND KRAMMER  741 
TABLE III 
Effect of T Cell Supernatants on LPS-induced IgM and IgG Secretion * 
LPS plus superna- 
tant from T cell 
lines added to 
culture 
Class of Ig secreted 
(percent of total secreted Ig):~ 
Experiment 1  Experiment 2  Experiment 3 
IgM  IgG  IgM  IgG  IgM  IgG 
LPS  99  t  93  7  ND  ND 
LPS + FS7-6.18  87  13  84  16  68  32 
LPS + PK 7.1.1a  83  17  79  21  65  35 
*  1  ×  106-2 X 10  s cells were cultured at 2 X 10S/ml  for 6 d, then labeled with 
[aH]leucine. Secreted material was analyzed by immunoprecipitation with 
RAMIg and S. aureus, and SDS-PAGE as described in Materials and Meth- 
otis. 
:~ Calculated from # and "t peaks on SDS-PAGE. 
TABLE IV 
Effect of T  Cell Supernatants on the IgG Subclasses Produced by LPS-treated 
B  Cells 
LPS plus superna- 
Experi-  tam from T cell 
ment  lines added to 
culture 
IgG subclass  se-  Increase in IgG 
creted (percent  subclass~ 
of total IgG)* 
IgGal  IgGa  IgGal 
IgG,  Ig(~b  IgGzb 
O  30  70  --  -- 
FS7-6.18  85  15  4  1 
PK 7.1.1a  97  3  14  1 
2  O  46  54  -  - 
FS7-6.18  97  3  38  1 
PK 7.1.1a  93  7  19  1 
* Based on the area under the yl or y3/y~ heavy chain peaks on SDS-PAGE. 
cpm of yl or y3/y~ chain of secreted IgG on SDS-PAGE  of LPS + superna- 
tant/LPS alone. 
were incorporated into total acid-precipitable material and into secreted Ig in both 
cultures. 
In experiments shown in Table III, we observed that <--7% of the Ig secreted by 
LPS-stimulated B cells was IgG. Approximately 50% of this IgG could not be bound 
by S.  aureus at neutral pH, suggesting that it was IgG1 (data not shown). In contrast, 
in cells cultured in the presence of LPS plus PK 7.1. la supernatant, 20-25% of the Ig 
secreted was IgG (Table III). Little or none of this IgG was bound to S.  aureus  (data 
not shown). To further confirm that the increase in IgG observed in B cells cultured 
in the presence of LPS plus PK 7.1. la was IgG1, the subclasses of IgG in the secreted 
material were analyzed by chromatography on protein A-Sepharose (to separate IgG~, 
IgG~, and IgG2b/IgGs [37]). The column fractions were then analyzed by immuno- 
precipitation and SDS-PAGE. The results of two experiments are shown in Table IV. 
LPS-treated  cells  secrete  predominantly IgG2b/lgGa with  lesser  amounts of IgG1; 
IgG2a was not detectable. In contrast, supernatants from FS7-6.18 or PK 7.1. la caused 
a  striking shift to IgGx production in LPS-treated cells. This is particularly apparent 742  T  CELL-DERIVED  B  CELL  DIFFERENTIATION  FACTOR(S) 
in the amount of each IgG subclass produced in the absence and presence of T  Cell 
supernatants  (Table III). It is evident that the increase in IgG PFC is due mainly to 
IgGl-secreting cells, since the amount of secreted IgG2b/IgG3 is similar in the presence 
an¢l absence of the T  cell supernatants. 
Discussion 
This paper describes a  lymphokine(s)  produced by a  T  cell hybridoma and  two 
alloreactive  long-term  T  cell  lines  that  markedly  increases  the  recovery of IgG- 
secreting cells after culture of murine B cells in the presence of LPS. We have termed 
this lymphokine BCDF.  Whereas LPS alone induces secretion of small amounts of 
IgG2b/IgGa  and  IgG1,  the  combination  of LPS  and  BCDF  induces  a  substantial 
increase in IgG1.  The cells producing IgGx in the presence of LPS and BCDF were 
originally sIgG-, suggesting that LPS-stimulated B cells are induced to switch in the 
presence of BCDF. 
Secretion of IgG can be induced in murine B cells in vitro by the mitogen, LPS (7, 
14-17).  The  LPS-mediated  induction  of IgG  secretion  has  been  shown  to  be  T 
independent and optimal at low cell density (7, 15). Our results are entirely consistent 
with these findings. The fact that [gG secretion is optimal at low initial cell densities 
suggests that several rounds of cell division may be required to obtain a switch to IgG, 
and there is evidence to support this contention (43, 44). We found that the addition 
of supernatants  from some T  cell  lines  (FS7-6.18  and  PK  7.1.1a),  but  not  others 
(C.C3.11.75, B.151-K12, BW 51477 T33F6, PC-AKR CL 96, PC-AKR CL 29), could 
greatly enhance the in vitro IgG response. This enhancement occurred independently 
of the presence of T  cells in  the culture and  was optimal at  low cell density. The 
enhancement  of IgG  secretion by the  T  cell supernatants  was  dependent  on  the 
presence of LPS, suggesting the necessity for a specific signal induced by LPS. This 
could be a proliferative signal per se, or one that induces receptors for BCDF. 
Several lines of evidence indicate that the cells secreting IgG in both antigen and 
LPS-treated cultures arise from IgM-bearing cells:  (a) early (but not late) addition of 
anti-# to cultures of normal spleen cells suppresses both IgM and IgG secretion (41, 
45, 46);  (b) in limiting dilution analysis of LPS-treated B cells, IgG PFC appear in 
wells that  first contain a  clone of IgM secreting cells (14); and  (c) removal of IgG- 
bearing cells does not decrease the appearance of IgG secreting cells in LPS-treated 
cultures  (17).  Nevertheless, we  felt it was  essential  to prove whether or not  BCDF 
selects and expands B cells already bearing IgO under our experimental conditions. 
To  demonstrate  that  sIgG-  cells  were  the  precursor  cells  for  BCDF-induced  IgG 
secretion, essentially all sIgG  + B cells were removed by cell sorting and the sIgG- cells 
were cultured in the presence of LPS and BCDF. In these experiments, the sIgG- B 
cells secreted amounts of IgG similar to those secreted by unsorted B cells, indicating 
that the precursors of the IgG secreting cells were originally sIgG-. 
The mechanism  by which BCDF specifically increases recovery of IgG secreting 
cells is not known. Two possibilities are: (a) BCDF may selectively expand the B cell 
population  that  has  been  induced  to  switch  to  IgG  by LPS,  thus  increasing  the 
number of progeny of a given clone; .or (b) BCDF may increase the number of clones 
that switch. A distinction between these two possibilities may be approached experi- 
mentally by determining the effect of BCDF on the IgG precursor frequency using 
limiting dilution techniques (14). The results of such experiments (Krammer, Isakson, ISAKSON, PURLS, VITETTA, AND KRAMMER  743 
Pure, and Vitetta,  manuscript  in  preparation)  support  the contention that  BCDF 
increases the precursor frequency but not the burst size of LPS-induced IgG secreting 
cells. This finding further suggests that BCDF enhances a switch from IgM to IgG. 
Several reports have demonstrated that soluble products of T  cells can stimulate B 
cell differentiation (47, 48). Typically, these T  cell factors have been obtained from 
mixed populations of T  cells and  their biochemical characterization has remained 
elusive. Recently, however, the establishment  of long-term T  cell lines  (49-51) has 
allowed immortalization of particular T  cell populations; this has greatly facilitated 
studies of T  cell-derived lymphokines (18,  19, 33, 34). There are several reports of the 
establishment of T  cell lines and hybridomas that secrete products which induce Ig 
secretion (36, 38, 39). Some of these factors appear to induce Ig secretion alone (26, 
52-55)  while others  may require  the  presence of antigen  (36,  39).  Whether these 
factors  are  identical  or  related  to  each  other  is  not  clear;  their  relationship  to 
conventionally defined TRF is not known. The two we have tested (CC3.11.75 and 
B 151K 12) appear to induce predominantly IgM secretion (26). 
The mechanisms by which T  cells regulate synthesis of particular Ig isotypes are 
not  understood.  Ishizaka  and  co-workers  have  demonstrated  that  helper  factors 
specific for IgE can be induced by various stimuli  (24,  25).T cells can also influence 
the IgG subclass secreted by B cells (12,  13). Data from in vivo experiments suggest 
that IgG3 secretion occurs independently of T  cells, whereas IgG1 secretion is strongly 
T  cell dependent (8,  10). Rosenberg and Chiller (20) showed induction of polyclonal 
class-specific Ig secretion by several nonspecific stimuli. Whereas some T  cell stimuli 
(e.g., Con A)  induced increases in all classes of IgG, others (e.g., complete Freund's 
adjuvant)  induced  primarily  IgG1  and  IgG2  secretion.  Thus,  there  is  an  in  vivo 
precedent for our finding that T  cells can regulate the subclass of IgG produced by 
polyclonally activated B cells. Using an in vitro system, Augustin et al. (21, 22) have 
demonstrated that the direct interaction of T  cells with polyclonally activated B cells 
or B cell blasts results in an increase in IgG1 secretion. In addition, Elson et al.  (23) 
have shown that Con A-activated Peyer's patch cells contain high numbers ofT cells 
that  drive LPS-induced B  cells specifically to IgA secretion. Taken together, these 
studies indicate that the secretion of specific classes of Ig can be regulated by T  cells 
or their soluble products. 
The  mechanism  by  which  B  ceils  switch  isotype  synthesis  is  beginning  to  be 
understood at the molecular level. Two different types of models have been proposed: 
(a) switching may be a stochastic process in which cells switch in a random fashion 
to secretion of previously unexpressed isotypes. The likelihood of productive recom- 
bination with a particular C region may, therefore, depend on such factors as distance 
from the C# gene, number and type of switch recombination sites (56-59), etc.;  (b) 
switching may be due to the directed induction of a particular isotype. Thiv .zould be 
accomplished by isotype specific factors that act at the plasma membrane of B cells 
and  direct  particular  DNA  rearrangements.  The  two  models  are  not  mutually 
exclusive and there could be both random and isotype directed elements involved in 
switching. Mongini et al. (13) observed that in the absence of T  cells, the magnitude 
of each isotype response to a  T-independent antigen exactly mimicked the 5' to 3' 
order of the immunoglobulin H-chain genes ~, Tz, yl, y2b, y2a). Thus, the likelihood 
of switching to a given subclass would decrease with increasing distance from the C# 
gene. This observation  is  consistent with  a  stochastic model.  T  cells might  simply 744  T  CELL-DERIVED  B  CELL  DIFFERENTIATION  FACTOR(S) 
increase the frequency of switching nonspecifically by driving cell division and/or by 
increasing the levels of enzymes responsible for switching. In contrast, reports of class 
specific T  cells (20-25)  and T  cell factors support a  model of directed induction of 
particular isotype switches. The present data do not distinguish between these models. 
It would be of interest to extend the period of culture to determine whether BCDF 
can cause switching to  Ig isotypes whose C-region genes map  further downstream 
(e.g., IgA). If so, it would indicate that BCDF is not specific in inducing switching to 
synthesis of a particular isotype. 
We have not yet attempted to purify BCDF. Instead, we have relied on a  variety 
of biological assays performed on the BCDF-containing supernatants for the identi- 
fication of lymphokine activity (Table I). From these comparisons, we conclude that 
none of the conventionally-defined lymphokines tested, with the possible exceptions 
of Eo-CSF, E-CSF, or HCSF, mediate this effect. Because the PK lines were derived 
by allogeneic stimulation, it  is  possible  that  they produce  allogeneic effect factor 
(AEF) (60) and that AEF is responsible for the effects we observed. However, AEF is 
reported to be most effective on cells expressing the haplotype of the stimulator cells 
(60, 61).  In the experiments reported here, BCDF induced IgG secretion by B cells 
expressing a  haplotype (H-2  a)  different from that of the stimulator cells (H-2b).  In 
other experiments  (manuscript  in  preparation),  we have shown that  BCDF works 
equally well using strains carrying the H-2  k and H-2  b haplotype. Therefore, although 
we  cannot  formally exclude  the  possibility  that  BCDF  is  AEF,  we  regard  this 
possibility  as  unlikely.  In  any  case,  the  lack  of an  overt  correlation  with  other 
lymphokines, in particular TRF, suggests that a newly defined T  cell factor may be 
present in the supernatants of these two lines and that this factor affects differentiation 
of B cells.  It should be  noted that the two lines  (C.C3.11.75  and B.151-K12)  that 
produce a  factor which induces polyelonal IgM secretion (26), do not stimulate IgG 
secretion in this system; thus, BCDF is distinct from this activity as well. The fact 
that the FS7-6.18 supernatant, which contains interleukin 2 (IL-2) but not TRF (33) 
can induce IgG secretion, raises the possibility that IL-2 can mediate this effect (even 
though  the  PK  7.1.1a  and  PK  7.1.2  supernatants  lack  both  IL-2  and  TRF).  In 
experiments with Dr. S. Gillis (Fred Hutchison Cancer Center, Seattle, WA), we have 
found that  purified  IL-2  has  no  BCDF  activity (data  not  shown).  This  strongly 
suggests that both FS7-6.18 and the PK 7.1.1a and 7.1.2 lines secrete a  lymphokine 
that induces B cell differentiation but that BCDF is not IL-2 or TRF. 
Summary 
Culturing BALB/c B cells for 6 d at low cell density in the presence of lipopolysac- 
charide (LPS)  results in the appearance of a  small number of IgG plaque-forming 
cells  (PFC).  The  addition of supernatants  from eoncanavalin A  (Con A)-induced 
alloreactive (AKR anti-B6) long-term T  cell lines (PK 7.1.1a and 7.1.2)  or a  T  cell 
hybridoma (FS7-6.18)  to LPS-treated B cells resulted in a  marked increase in IgG 
PFC  (3-10-fold  higher than  in  cultures  treated with  LPS alone). The  number of 
induced IgG PFC was not affected by removing IgG-bearing cells on the fluorescence- 
activated  cell  sorter,  indicating  that  T  cell-derived  B  cell  differentiation  factor 
enhances isotype switching of sIgG- cells, rather than selecting and expanding pre- 
existing  subpopulations  of sIgG  +  cells.  We  also  investigated  the  subclass  of igG 
produced in the absence or presence of T  cell factors and found that PK 7.1.  la, PK ISAKSON, PURLS, VITETTA, AND KRAMMER  745 
7.1.2, and FS7-6.18 supernatants selectively incre~ed IgGa production. Several other 
T  cell supernatants containing a variety of lymphokines had no effect, suggesting that 
PK 7.1. la, PK 7.1.2, and FS7-6.18 lines produce factor(s) that can specifically enhance 
the recovery of IgG secreting cells in culture in the presence of LPS. These factors, 
which we have termed B cell differentiation factors, are different from interleukin  1, 
interleukin 2, T  cell-replacing factor, colony-stimulating factor, macrophage-activat- 
ing factor, and immune interferon. Our results suggest that soluble factors produced 
by T  cell lines and hybridomas can markedly influence both the class and subclass of 
Ig produced by B cells. 
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